Trials / Completed
CompletedNCT00331916
AL-15469A for the Treatment of Bacterial Conjunctivitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 1 Month
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine whether AL-15469A is safe and effective in the treatment of bacterial conjunctivitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | quinolone |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2007-05-01
- First posted
- 2006-05-31
- Last updated
- 2009-09-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00331916. Inclusion in this directory is not an endorsement.